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A B S T R A C T
The development of antimicrobial agents that target and selectively disrupt bioﬁlms is a pressing issue since, so
far, no antibiotics have been developed that achieve this eﬀectively. Previous experimental work has found a
promising set of antibacterial peptides: β2,2-amino acid derivatives, relatively small molecules with common
structural elements composed of a polar head group and two non-polar hydrocarbon arms. In order to develop
insight into possible mechanisms of action of these novel antibacterial agents, we have performed an in silico
investigation of four leading β2,2-amino acid derivatives, interacting with models of both bacterial (target) and
eukaryotic (host) membranes, using molecular dynamics simulation with a model with all-atom resolution. We
found an unexpected result that could shed light on the mechanism of action of these antimicrobial agents: the
molecules assume a conformation where one of the hydrophobic arms is directed downward into the membrane
core while the other is directed upwards, out of the membrane and exposed above the position of the membrane
headgroups; we dubbed this conformation the “can-can pose”. Intriguingly, the can-can pose was most closely
linked to the choice of headgroup. Also, the compound previously found to be most eﬀective against bioﬁlms
displayed the strongest extent of this behavior and, additionally, this behavior was more pronounced for this
compound in the bacterial than in the eukaryotic membrane. We hypothesize that adopting the can-can pose
could possibly disrupt the protective peptidoglycan macronet found on the exterior of the bacterial membrane.
1. Introduction
The emergence of strains of bacteria resistant to even the most
powerful current antibacterial agents can be seen as one of the most
serious crises facing humanity in the coming decades; the development
of novel antibacterial drug therapies is an urgent priority. Additionally,
microorganisms are now recognized to switch between two diﬀerent
lifestyles: a single-cell state, responsible for acute infections, and a
multicellular state, associated with persistent diseases. The multi-
cellular state is known as a bioﬁlm, deﬁned as an aggregated community
of bacteria contained within a self-produced matrix [1]. Infections in
the form of bioﬁlms have been found to possess signiﬁcantly higher
tolerance to antibiotics and the host immune system [1]. As of yet, no
antibiotic has been developed that eﬀectively and selectively disrupt
bioﬁlms in human tissue. While the development of new antimicrobial
agents is an urgent priority, the need for novel agents focused on the
disruption of bioﬁlms is even more pressing.
Antimicrobial peptides, or host defense peptides, are an ancient, in
terms of evolution, component of the immune system of virtually all
multicellular organisms [2]. They are thus considered as a promising
source of new potent antibiotics: lead molecules in the design of pep-
tidomimetics against highly resistant bacteria [3]. While the structural
diversity of antimicrobials is signiﬁcant, they are, in general, short,
cationic and amphiphilic; i.e. they possess distinct hydrophilic and
hydrophobic components: this allows them to bind to lipid-water in-
terfaces [4]. The mechanism through which they perform their anti-
microbial activity is multifaceted; it includes the disruption of the
physical integrity of pathogen cell membranes, activation of host cell
immune responses and induction of pleiotropic eﬀects in a range of
diﬀerent cell types [4,5].
Several antibiotics based on antimicrobial peptides are currently in
commercial development [6]. In spite of the fact that a considerable
eﬀort has been expended in their development over more than a
decade, an unacceptable level of toxicity remains a problem; this limits
the use of antimicrobial peptides in clinical settings, in particular, when
administered orally [6,3]. A class of antibacterial peptides that has
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recently shown signiﬁcant promise is β2,2-amino acid derivatives
[7,8,9]. These are relatively easy to produce, as they are small mole-
cules with limited structural complexity. Thus, it can be expected that
they would prove more suitable for oral administration, as suggested by
phospholipid vesicle permeability assays [8,9]. Not only have they
demonstrated high potency against planktonic Gram-positive and -ne-
gative bacterial cells, including methillin-resistant S. aureus bacteria,
MRSA, but they have also, in particular, been found to be powerful
bioﬁlm disrupting agents [7]. Namely, the most potent β2,2-amino acid
derivative, labeled “A2 ”, was demonstrated by Ausbacher et al., to be
16-fold more potent against S. aureus bioﬁlms than penicillin G and
resulted in an almost complete removal of bacterial cells at higher
concentrations [7]. In that study, it was suggested that the small size of
A2 would accelerate its diﬀusion into bioﬁlms and that a membrane
destabilizing eﬀect could be responsible for its enhanced anti-bioﬁlm
activity; the exact mechanisms behind the anti-bioﬁlm eﬀect of A2,
however, still remain unclear. Furthermore, the β2,2-amino acid deri-
vatives have low haemolytic activities against human red blood cells,
thus showing the promise of reduced toxicity. While there is signiﬁcant
evidence of the potential of this class of antibacterial agents, their mode
of action is, however, poorly understood; it has been suggested that
β2,2-amino acid derivatives, as in the case of some other antimicrobials,
lyse bacterial cell membranes by disrupting their physical properties
[7,4], however, other mechanisms cannot be excluded.
Obtaining a detailed mechanistic understanding of the activity of
antimicrobial peptides, particularly their potential to disrupt bioﬁlms,
is extremely challenging; performing in vitro studies has proved to be a
very daunting task for a number of reasons. For example, a given an-
timicrobial peptide may or may not display activity depending on the
experimental conditions, which in turn can aﬀect the ability of clinical
isolates to form bioﬁlms [10]. Computational molecular dynamics
modelling (MD) provides a new, unique, window into supramolecular
systems. It is able to provide insight into interactions, with atomistic
resolution, that is not accessible experimentally; in silico methodologies
can make progress where in vitro methodologies have, in the past, been
limited. Modelling a section of a biomembrane is a mature tool in
biophysics that can be used to study the behavior of diﬀerent bio-
membranes and their interaction with drug, or other xenobiotic, mo-
lecules [11]. This technique has been used, in past work, to study the
behavior and action of antimicrobials [12,13,14,15]. In order to obtain
more insight into the mechanism of action of this class of antimicrobial
agents, we have studied a set of β2,2-amino acid derivatives interacting
with mammalian- and bacterial-like lipid bilayers in silico through
atomistic molecular dynamics simulation. Our goal is to reveal 1) their
conformational features at the lipid-water interface and 2) speciﬁc in-
teractions with phospholipids.
From the set of promising antimicrobial β2,2-amino acid derivatives,
we chose to model the compounds that have been previously coined as
A2, A3, A5 and A6 [7]. The chemical structures of the four compounds
are shown in Fig. 1; all compounds are amphiphilic in nature, with a
hydrophilic C-terminal cationic head group and two hydrophobic hy-
drocarbon arms. Between the four compounds there are two separate
head groups, one shared by compounds A2 and A3 (1,2-diaminoethane)
and the other shared by A5 and A6 (N,N-dimethylaminoethanol) and
two separate arm structures, one shared by A2 and A5 (2-naphthalene
methylene side-chains) and the other shared by A3 and A6 (para-tert-
butyl benzyl side-chains). The hydrophobic arms of A2 and A5 are more
polar than those of A3 and A6 based on the octanol-water partitioning
of A2 and A3 (3.4 vs. 3.7) [8]. In addition, the head group of com-
pounds A5 and A6, with double methylation of the C-terminal end
primary amine and introduction of an ester linkage, is less polar in
comparison to that of A2 and A3, without methylation. Further, the
presence of an ester linkage in compounds A5 and A6 renders the
molecules less polar.
All of the four above mentioned antimicrobial compounds were
found to be potent in destroying planktonic S. aureus cells and their
bioﬁlms, however, the selectivity of these compounds against bacteria,
vs. their haemolytic activities, showed substantial diﬀerences.
Compounds A2 and A5 were the most selective for the case of plank-
tonic and bioﬁlm bacterial cells, however, they were slightly less potent
against planktonic bacterial cells, in comparison to compounds A3 and
A6 [7]. Regarding anti-bioﬁlm activities, the compounds A2 and A3
were more potent in destroying S. aureus bioﬁlms than A5 and A6 [7].
Intriguingly, it had been shown by Hansen et al. that by increasing the
hydrophobicity of the non-polar arms, more eﬀective antimicrobials
were acquired in the context of planktonic bacterial cells [8], a result
conﬁrmed by the study of Ausbacher et al. [7]. In contrast, concerning
the polar component of the compounds, A5 and A6, with the less hy-
drophilic headgroup, were found by Ausbacher et al., [7] to have a ∼
25–33 % reduction in antimicrobial activity, in comparison to com-
pounds A2 and A3. Thus, the experimental evidence clearly shows that
potency against bioﬁlms is more strongly correlated to the structure of
the headgroup than to the nature of the hydrophobic tails. Regarding
selectivity, i.e. potency against microbial target vs. potency against host
cells, the reverse was found to be true: compounds A2 and A5 (2-
naphthalene methylene side chains) had signiﬁcantly enhanced se-
lectivity against planktonic bacterial cells in comparison to that found
for A3 and A6 (with para-tert-butyl benzyl side chains) [7].
As β2,2-amino acid derivatives are amphiphilic, it can be expected
that they concentrate at the lipid-water interface of cell membranes and
interact with the positively charged amine groups of the phospholipid
(PL) head groups by plausibly forming salt bridges governed by ionic
interactions and hydrogen bonds (H-bonds). Meanwhile, the hydro-
phobic tails are expected to interact with the acyl chains of PLs. A key to
their mode of action is how the fashion in which they interact with both
the membrane of the cells of the host and the membrane of the target
bacteria diﬀers; to shed light on this, we simulated the chosen anti-
microbials interacting with mammalian- and bacterial-like lipid bi-
layers.
Though our simulations we found evidence that, while all com-
pounds, as expected, located to the lipid-water interface, they exhibited
unexpected diﬀerences in their behavior at the membrane surface.
Speciﬁcally, they diﬀered in the extent to which their hydrophobic
arms were buried in the membrane core. In particular, the compounds
were observed to sometimes display a conformation characterized by
one arm directed down into the membrane while the other was thrust
almost vertically out of the membrane, what we refer to as the “can-can
pose” found, surprisingly, to be predominantly correlated to the choice
of hydrophilic headgroup. Intriguingly, in addition to being more
Fig. 1. The molecular structures for the four β2,2-amino acid derivatives that we
have studied in this contribution.
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prevalent in the compounds with the more hydrophilic headgroup (A2
and A3), for these compounds the prevalence of this conformation was
also greater in the bacterial than the mammalian membranes, while the
reverse was the case for compounds A5 and A6. These ﬁndings shed
light on the mechanism behind the diﬀerences in the activity of these
compounds and, hopefully, help pave the way for the development of
yet even more eﬀective antimicrobial agents.
2. Materials and methods
2.1. Systems simulated
We used computational molecular dynamics (MD) simulation to
study the four compounds mentioned in the introduction interacting
with two separate lipid membrane models, to study eukaryotic (mam-
malian, the patient or host) and prokaryotic (bacterial, the target)
membranes respectively. In order to model the eukaryotic and pro-
karyotic lipid membranes we must approximate the lipid compositions
in our simulations since incorporating thousands of diﬀerent lipids
species to MD simulations of lipid bilayers is, at least currently, out of
reach at the moment. Thus, here we have chosen to use two-component
lipid bilayer models to approximate mammalian and bacterial lipid
membranes which, importantly, diﬀer in surface charge. The eukaryotic
model membrane was composed of 1 - palmitoyl - 2 - oleoyl - phos-
phathidylcholine (POPC) and cholesterol (CHOL) molecules; the pro-
karyotic model membrane was composed of 1 - palmitoyl - 2 - oleoyl -
phosphathidylethanolamine (POPE) and 1 - palmitoyl - 2 - oleoyl -
phosphathidylglycerol (POPG). Essentially, the total charge of eu-
karyotic model membrane is 0, whereas the total charge of the pro-
karyotic model membrane is negative.
Both POPC:CHOL and POPG:POPE molar concentration ratios were
set to 3:1. All four antibacterial agents were simulated interacting with
both the aforementioned mammalian and bacterial membrane models,
for a total of eight systems; in each simulation ten of these molecules
were added to the water phase of these systems. As the antibacterial
agents and POPG have positive and negative charge respectively, for all
systems either Cl− or Na+ ions were added to achieve charge neu-
trality.
To investigate the eﬀect of initial conditions, additional simulations
were performed, with four of the antibacterial agents positioned within
the membrane core at the start of the simulation; while initialization
with the compounds studied in the solvent is the best model of the real
systems we study, the additional simulations with the molecules
starting the simulation in the membrane core will provide additional
insight. The compounds were inserted into the membrane core as fol-
lows: starting with a simulation with the compounds initialized in the
water phase, we took a frame from the simulation after 1 μ s of simu-
lation; four antimicrobials were pulled to the center of the bilayer so
that both hydrophobic arms were buried in lipids in each case; all other
antimicrobials were removed from the systems. A lower number of
antimicrobials were used in the simulation where the molecules were
initially placed into the lipid bilayer center, since placing 10+ highly
charged molecules (the total charge of one antimicrobial is +2) into the
center would disrupt the membrane structure; additionally, the re-
sulting 20+ total charge in a hydrophobic phase without counter ions
would result in a highly unphysical system.
Also, to insure that none of our observations were artefacts of the
speciﬁc force ﬁeld chosen, we repeated a subset of our simulations with
two alternate force ﬁeld parameter sets (details described below). We
also simulated one system with physiological salt concentration pre-
sent, to demonstrate that the presence of salt has no eﬀect on the
phenomena observed. In addition, we simulated two replica exchange
simulations to show that the simulation with four A2 or A6 anti-
microbials at the center of the bilayer initially converge to the same
conformations as in the case of simulations where antimicrobials were
initially placed in the water phase (see details and discussion in the
Supplementary material). See Supplementary Table S1 in the
Supplementary material (SM) for the full list of all systems simulated
and number of each variety of molecule in each simulation.
2.2. Force ﬁeld parameter sets
The complementary MacRog [16] and OPLS-AA [17] (optimized
potentials for liquid simulations - All Atom) force ﬁelds were utilised for
lipids and β2,2-amino acid derivative molecules, respectively, in simu-
lations carried out with all atom resolution; partial charges for β2,2-
amino acid derivates were parametrised using the Gaussian and
Amber14 software packages [18,19]. First, the molecules were fully
optimized at the Hartree-Fock (HF) level with the 6-31G* basis set. This
was followed by calculation of atomic charges with the Merz-Kollman
scheme [20] employing the HF level and 6-31G* basis set. The charges
obtained in this way were replaced by the restrained electrostatic po-
tential (RESP) charges. In this step, the Antechamber tool, included in
the Amber14 modelling package, was used [19]. The Lennard-Jones
and bonded parameters were based on the standard OPLS-para-
metrization [17]. We repeated a subset of our simulations using two
alternative potential sets: the lipids modelled using Slipids [21,22] and
Lipid14 [23] potentials, in each case with the antimicrobial agents
modelled using the Generalized Amber Force Field (GAFF) [24], com-
patible with both these lipid potential sets; further details regarding the
construction of these systems is found in SM, Section S1. For all po-
tential sets considered, the same partial charges, calculated using the
protocol described above, were used.
2.3. Simulation parameters
Molecular dynamics simulations were conducted using the
GROMACS simulation package (version 5.1.2) [25,26]. All systems,
including those carried out with the alternate potential sets, were ﬁrst
energy minimized using the steepest descent algorithm with 5000
minimisation steps. After this, short equilibration simulations were
carried out to stabilise pressure ﬂuctuations followed by 2 μ s of si-
mulation at constant temperature and pressure. The time step was set to
2 fs; temperature and pressure were maintained at 310 K and 1 bar,
respectively. Berendsen coupling schemes were utilised to achieve
constant temperature and pressure during the short equilibration si-
mulations [27]. After this, for the 2 μ s simulations, Nosé-Hoover and
Parrinello-Rahman coupling algorithms were employed, to treat tem-
perature and pressure, respectively [28,29]. Semi-isotropic pressure
coupling was used. The coupling constants chosen, for the aforemen-
tioned thermostat and barostat, were 1 ps−1 and 12 ps−1, respectively.
Water, plus ions, lipids and antimicrobial compounds were coupled to
separate heat baths. A cut-oﬀ of 1 nm was used for the Lennard-Jones
interactions; electrostatic interactions were handled using the particle-
mesh Ewald method with a real space cut-oﬀ of 1 nm [30]. The LINCS
algorithm was applied to constrain bond lengths [31].
2.4. Analysis details
All the analysis programs listed here are part of the GROMACS si-
mulation package [25,26]. The gmx_traj program was used for mon-
itoring the center of mass of the antimicrobial agents as a function of
time. In addition to this, the orientation of non-polar components of the
antimicrobial agents were analyzed using the gmx_traj program. More
speciﬁc calculation of the angles between the hydrophobic arms and the
bilayer normal were calculated by using a code built in house (see
Results 3 for further details). Mass density proﬁles were produced using
the gmx_density program; the Z-axis of the simulation boxes were di-
vided into 100 slices and the average number density, over the whole
simulation trajectory, was calculated in each of them. The number of
hydrogen bonds formed between selected atoms of the antimicrobial
agents and lipids was determined using the gmx_hbond program; the
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maximum distance between an H-bond donor and acceptor was set to
0.35 nm and the maximum angle formed by hydrogen bonding atoms
(hydrogen-donor-acceptor) was set to 30 °, a standard, widely accepted,
deﬁnition of an H-bond in the context of MD simulations carried out
with all atom resolution [32,33,34]. Calculations of tilt angles of the
polar head and non-polar arms of the antimicrobial agents, with respect
to the lipid bilayer normal, were calculated using the gmx_gangle
program. Radial distribution functions (RDFs) were determined using
the gmx_rdf program. The lateral RDFs for all lipids around the anti-
microbial compounds were determined; center of masses were used in
all calculations. The gmx_sasa program was used to calculate the sol-
vent accessible surface of the antimicrobial compounds. All visualiza-
tion of molecular conﬁgurations was carried out using Visual Molecular
Dynamics (VMD), version 1.9.3. [35]
3. Results
We ﬁrst monitored a visualization of the trajectories for the eight
systems studied; in every case the antimicrobial agents were seen to
clearly locate to the position of the lipid headgroups. As shown in
Supplementary Fig. S1 in SM, for both initial positions of the anti-
microbials, solvent and membrane core, the position of the central
carbon atom of all antimicrobials was seen to locate to the position of
the phosphate headgroups of the lipids; in all cases this was seen to
occur during the ﬁrst μ -second of the simulation; for further details see
SM, Section S2. Analysis of the raw time series data for all other cal-
culated properties (more details below) also indicates that equilibration
has roughly been achieved by the time 1 μ s has elapsed (again, see SM,
Section S2); the results from the last microsecond of the 2 μ s simulation
are thus used for all analysis. The results for the systems where the
agents were initialized within the membrane did not, however, quan-
titatively match the results for the systems where the agents were in-
itialized in the solvent (see SM, Section S3). We were, however, using
the alternate potential set mentioned above, able to show convergence
of the results from the two starting points; the Slipids+GAFF potential
set, while obtaining the same static properties, sampled new con-
formations more quickly and we were able to accelerate the sampling
further still using replica exchange in order to achieve this result,
shown in the Supplementary materials, Fig. S12.
Our simulations conducted with physiological salt ion concentration
(see SM, Section S4) show no eﬀect on our results due to the presence of
the ions. In the remainder of the simulations we carried out, we have
not considered ions in the solution; investigation of any resulting eﬀect
would be problematic since the bacteria could be in several diﬀerent
ionic environments, e.g. in the intracellular environment the salt pre-
sent is predominantly KCl while in the intercellular environment the
salt present is predominantly NaCl. Our simulations carried out with the
alternate potentials did not show any qualitatively diﬀerent results
concerning the static properties, however, the dynamics of these si-
mulations was seen to occur more quickly (see SM, Section S4); since
our analysis is not dependent on any dynamic observables, this is not an
issue. The remainder of this paper thus discusses only the eight systems:
each of the four agents studied, each interacting with both mammalian
and bacterial membrane; the agents are initialized outside the mem-
brane and the last μ-second of the simulated trajectories are considered
for all analysis.
Now that it has been determined that the compounds all locate to
the position of the membrane headgroups, we investigate further details
regarding the orientation and behavior at the interface. As mentioned
in the introduction, the compounds can all be divided into two com-
ponents, a hydrophilic head and hydrophobic arms, as shown in
Fig. 2A. We plotted the mass density proﬁles for both components of the
compounds separately, relative to the position of the phosphate head-
group, as determined from the position of maximum density for the
phosphate group for all eight systems, shown in Fig. 2B (see SM for full
mass density proﬁle results, Figs. S5 and S6). The mass density proﬁle
measures the relative densities of speciﬁc atoms, atom groups or mo-
lecules within the system along the membrane normal; it serves as a
measure of where in the membrane these diﬀerent elements sit. We see
that, in all eight cases, the hydrophilic head sits just inside the mem-
brane from the phosphate headgroup while the hydrophobic tails pre-
sent a double peaked distribution, thus locating either outside or inside
the membrane. Comparing the mass density proﬁles for the four dif-
ferent compounds, we see a striking diﬀerence that results from al-
teration of the hydrophilic head of the compound: the compounds A2
and A3, with the more polar head group, showed a signiﬁcantly greater
presence of the hydrophobic tail outside of the membrane than the case
for compounds A5 and A6. Another useful quantity that can be calcu-
lated is the Solvent Accessible Surface Area (SASA), a measure of the
relative surface area of atom group or molecule with the solvent. Re-
sults for the SASA for the components of each of the four compounds in
both membranes, shown in Fig. 2C, corroborates the picture we see
from the mass density proﬁle results: compounds A2 and A3 show
signiﬁcantly greater exposure to the solvent by their hydrophobic arms.
Interestingly, we see the reverse pattern concerning the exposure to the
solvent of the hydrophilic head: SASA of the hydrophilic component is
signiﬁcantly greater for compounds A5 and A6 than for A2 and A3.
Concerning the diﬀerence between behavior of the compounds in
bacterial and mammalian membranes, we see, in all cases, both hy-
drophobic and hydrophilic components sit deeper in the membrane and
have less exposure to the solvent, i.e. lower SASA, in the mammalian
than in the bacterial membrane, thus all compounds penetrate more
deeply into the mammalian than the bacterial membranes.
We next investigated the orientations of the two hydrophobic arms
of the compounds, to determine the mechanisms through which they
have their characteristic distribution, located either outside or inside
the membrane. We deﬁned two vectors, between the central carbon
atom and the end carbon atoms of the two hydrophobic arms. For each
of the eight systems, we constructed a heat map of angle between the
membrane normal and each of the two vectors, with one on the x axis
and the other on the y axis, shown in Fig. 3A. Analyzing this, we see two
patterns of distribution: 1) one arm buried in the membrane, pointed
down and the other pointed up out of the membrane and 2) both arms
buried in the membrane. The compounds thus sometimes have both
arms within the membrane and sometimes one out of the membrane,
like a can-can dancer kicking her leg into the air (see images in Fig. 3A).
We see that the extent to which the compounds are behaving in each of
these fashions diﬀers between the diﬀerent systems, as shown in the
diﬀerences between the heat maps; membranes where each of the two
states are prevalent are visualized in Fig. 3B. In order to quantify this,
we deﬁned two states for the molecule: the molecule was in the “both
arms buried” conﬁguration when both end carbon atoms of the two
hydrophobic arms were below the phosphate groups of lipids and “one
arm buried” when one was above, what we dub as the “can-can pose ”.
The results of the prevalence of the “both arms buried” conﬁguration, in
each system, is shown in Fig. 3C. We now see another striking diﬀer-
ence between the compounds with the diﬀerent hydrophilic headgroups
(A2 and A3 vs. A5 and A6): for A2 and A3 the extent to which the “both
arms buried” conﬁguration is present is greater for the mammalian than
bacterial membrane and for A5 and A6 this is reversed; once again, we
see the dominant eﬀect of the choice of hydrophilic headgroup.
Now that we have shown the important role the hydrophilic head
group plays, we analyze the nature of the interaction between the hy-
drophilic headgroup and the membrane. As shown in Fig. 4A, the
compounds A2 and A3 share a common hydrophilic headgroup with
three H-bonding sites, while for A5 and A6 there are two H-bonding
sites. In particular, the presence of two primary amines and one sec-
ondary amine in compounds A2 and A3 are able to form seven H-bonds,
whereas A5 and A6 have one primary amine and one tertiary amine
that are able to form four; in all cases the compounds possess H-bond
donor sites (hydrogen atoms) that interact with the H-bond acceptor
sites (oxygen atoms) in the membrane headgroups. In addition, we
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Fig. 2. Analysis of the positioning in the membrane of the hydrophilic and hydrophobic components of the four compounds, identiﬁed in part A, B) mass density
proﬁle results showing location within the membrane of the two components with respect to the position of the phosphate headgroup peak and C) the solvent
accessible surface area (nm2), i.e. area exposed to solvent outside the membrane, for the two components of each of the four compounds.
Fig. 3. Analysis of the relative orientation of the hydrophobic arms of the compounds: A) heat maps of the orientations of the two hydrophobic arms; the x and y axes
are the angle of the ﬁrst and second hydrophobic arms with the membrane normal respectively, B) visualization of the compounds A3 and A6 in the bacterial
membrane, A3 shows a greater prevalence of the one arm buried, “can-can pose” conﬁguration, C) bar graph of the percentage of instances of compounds in the two
arms buried conﬁguration for the four compounds in both mammalian and bacterial membranes.
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must also consider the attractive electrostatic interaction between the
positively charged amine groups of antimicrobials and the negatively
charged phosphate groups of lipids. These, together with the formation
of a number of hydrogen bonds, result in the formation of salt-bridges.
For the mammalian membrane, the compounds form H-bonds with
the head groups of the POPC lipids and for the bacterial membranes, H-
bonding occurs with both the POPG and POPE lipids. Corroborating the
fact that the important dominant interactions are between the com-
pound headgroups and the POPC or POPG/POPE lipids, results for the
RDF between membrane molecules and the compounds show, as ex-
pected, that the compounds locate laterally in the membrane to the
positions of these molecules and not to cholesterol (see SM, Section S5).
We calculated the prevalence of these H-bonds, shown in Fig. 4B.
Compounds A2 and A3 clearly form a higher number of H-bonds with
POPC (77–82 % of total H-bonds), in the mammalian-like membrane
environment, when compared to the total number of H-bonds formed
with the bacterial-like membrane, comprised of POPG and POPE
(64–70 % of total H-bonds). The diﬀerence, however, diminishes when
studying H-bonds formed by compounds A5 and A6 in mammalian- and
bacterial-like lipid environments (85–87 % vs. 82–92 %, respectively).
This result highlights the role of the more hydrophobic polar head
group of A5 and A6 in their interaction with the lipid head groups.
Namely, the less polar head groups of A5 and A6 form equally strong H-
bonds with mammalian- and bacterial- membranes, whereas A2 and A3
form stronger H-bonds with mammalian membranes. In all systems, all
H-bonding sites participate in binding the compound to the membrane
as, in all cases, the H-bonding is primarily with the membrane lipid
head groups (phosphate groups). As the interaction of antimicrobial
amines with phosphate groups of lipids is also heavily governed with
the attractive nature of the opposing total charges of the groups, the
formation of salt-bridges is eminent. Thus, compounds are bound to the
membrane through the formation of salt-bridges and H-bonding with
the lipid head groups in addition to hydrophobic interactions between
the arms of the compound and the hydrophobic core of the membrane.
The behavior of the hydrophilic head of the four compounds will
play a key role in the overall behavior of the compounds. We have,
Fig. 4. Analysis of the interaction of the hydrophobic component of the compounds with the membrane headgroups: A) visualization of the H-bond forming sites for
both headgroup types present, B) percentage of H-bonds between compounds and membrane headgroups, POPC for the mammalian headgroups and POPE and POPG
for the bacterial membranes, C) orientation of the hydrophilic component of the compound.
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additionally, measured the angle of the hydrophilic head of the com-
pounds in the membrane, shown in Fig. 4B; here, we see a striking
diﬀerence between the two diﬀerent headgroups: the A2 and A3
headgroup sits ﬂatter in the membrane, closer to 90° from the mem-
brane normal.
Altogether, we see the choice of hydrophilic headgroup to have
more bearing on the interaction with the lipid membrane than the
choice of hydrophobic arm. The headgroup of compounds A2 and A3
sits ﬂatter in the membrane; it can be postulated that this altered or-
ientation of the headgroup gives rise to the greater propensity for the
compound to kick one of its arms out of the membrane: the can-can
pose. Of particular importance is how this behavior diﬀers in the bac-
terial and mammalian membrane; for compounds A2 and A3, with one
headgroup type, the can-can pose is more prevalent in the bacterial
membrane while for to other headgroup type, present in compounds A5
and A6, it is less prevalent in the bacterial membrane. We see less eﬀect
on the behavior of the compounds in the membrane resulting from the
choice of hydrophobic arm, however, one notable eﬀect is that com-
pound A2 has a signiﬁcantly greater occurrence of the can-can pose
than compound A3.
4. Discussion and conclusion
We used MD simulation to study four β2,2-amino acid derivatives
that have previously been investigated experimentally [7,8,9] inter-
acting with both models of bacterial and mammalian cell membranes;
the goal was to obtain insight into how their interaction with the
membranes of the target (bacterial, prokaryotic membrane) and the
host (cell, eukaryotic membrane) may diﬀer and how the behaviors of
the compounds diﬀer from each other. The structures of the compounds
were diﬀerentiated by both the hydrophilic head group and hydro-
phobic tails. All compounds were seen to locate to the lipid-water in-
terface, as was to be expected due to their amphiphilic nature. The
compounds, however, exhibited a striking behavior that was not an-
ticipated: in some cases one of the two hydrophobic arms was com-
pletely exposed to the water phase, directed outwards from the mem-
brane, whereas the other arm was buried and directed towards the
membrane core. We refer to this conformation as the “can-can pose ”.
What predominantly diﬀerentiated these four compounds was the ex-
tent of the occurrence of this conformation and, more importantly, how
this varied between the bacterial and cell membranes. Of particular
note, we found that the dominant eﬀect resulted from the structure of
the hydrophilic headgroup rather than the hydrophobic arms: com-
pounds A2 and A3, not only expressed a greater extent of the one-arm-
buried conformation, but, more importantly, this conformation was
more prevalent in the bacterial-like membrane than in the mammalian-
like membrane while, for A5 and A6, this behavior, that exhibited itself
to a much weaker extent, was reversed, i.e. more prevalent in the
mammalian-like membrane than the bacterial-like membrane. Between
compounds A2 and A3, compound A2 exhibited this phenomenon to a
stronger extent than A3; this was to be expected as A2 possesses the
slightly less hydrophobic 2-naphthalene methylene arms, as indicated
by the octanol-water partition coeﬃcients [8].
These ﬁndings provide new mechanistic insight that can possibly
explain the eﬃcacy of A2 and A3 as selective antimicrobial agents. An
essential factor regarding their eﬃcacy is the ability of these com-
pounds to preferentially interact with the target bacterial membranes in
a disruptive manner and to display a, relatively, reduced aﬃnity to-
wards the mammalian cell membranes of the host organisms. As de-
scribed in the introduction, the previously described experimental
studies [7] found that compounds A2 and A3 showed signiﬁcantly su-
perior biocidal eﬃcacy against bacterial bioﬁlms, in comparison to
compounds A5 and A6; eﬃcacy is thus predominantly correlated with
the choice of polar headgroup. On the other hand, selectivity was found
to be superior for compounds A2 and A5; selectivity is thus pre-
dominantly correlated to the choice of hydrophobic arms [7]. In our
simulation studies the prevalence of the can-can pose was pre-
dominantly correlated to the choice of polar headgroup, thus this
phenomenon may be more closely related to eﬃcacy than selectivity.
At this point, it is necessary to clarify what precisely, in this case,
MD simulation is and is not, capable of. What we have is a model, given
a set of assumptions, that isolates a speciﬁc element of the system being
studied. This is not a realistic visualization of all aspects of what hap-
pens when these antimicrobial agents encounter bacterial and cell
membranes, but rather a model for the behavior of individual com-
pound molecules, in isolation, at simpliﬁed model formulations of
bacterial and cell membranes. We have identiﬁed that a speciﬁc be-
havior, the can-can pose, correlates to eﬃcacy of the compounds to-
wards bacterial bioﬁlms; while this behavior, in isolation, is not the sole
mechanism of antimicrobial activity, it may play an important role in
the overall mechanism of activity. It is possible that diﬀerences in the
extent of the overall polarity of the speciﬁc antimicrobial molecule
could play a role in their selectivity and potency, however, we would
argue that it is highly unlikely that this is the sole explaining factor as,
in all simulations, all antimicrobials rapidly located to the lipid-water
interface; this indicated that all compounds possessed strong lipid bi-
layer aﬃnities for both membrane types. This issue is to be quantita-
tively investigated through a combination of experimental and com-
putational methodologies in future work. Additionally, it is possible
that, while the model membranes we constructed are designed to
highlight the diﬀerent properties of mammalian and bacterial mem-
branes, aspects of the membranes not included in the study could alter
our results; in some cases it has been found that such simpliﬁed
membrane models have failed to correctly model key aspects of the
properties of the membrane [36].
The primary eﬀect of the adoption of the can-can pose is the ex-
posure of a hydrophobic arm outside the membrane. Two possible
outcomes that lead to bactericidal eﬀects can be hypothesized: either
this could 1) induce local aggregation of the compounds driven by the
hydrophobic eﬀect, resulting in a large scale collective behavior that
disrupts the bacterial membrane structure or 2) the exposed hydro-
phobic arm outside the bacterial membrane could itself have a bac-
tericidal eﬀect. The latter hypothesis is particularly intriguing as it ﬁts
in well with our current understanding of the mode of action of anti-
bacterial agents. Bacteria express a protective peptidoglycan layer
outside of their cell membrane that forms a quasi-two-dimensional
crystal structure known as a macronet. The mode of action of conven-
tional antibiotics, including β-lactams (e.g., penicillins and cephalos-
porins), glycopeptides (e.g., vancomycin and teicoplanin) and dapto-
mycin, is to inhibit the activity of key enzymes that play a role in the
construction of the macronet. Antimicrobial peptides are not pepti-
doglycan synthesis inhibitors; they display a diﬀerent mode of action. It
has been suggested that they instead directly disrupt the structure of the
peptidoglycan macronet in single-cells [37], direct experimental evi-
dence, however, remains lacking. It is thus possible that the β2,2-amino
acid derivatives we have studied could be directly disrupting the
macronet through contact with the hydrophobic arm of the agent that is
exposed outside the membrane when it adopts the can-can pose.
Beyond the immediate mechanism we have found here, relating to
these speciﬁc compounds, this can be seen as a case study of how in
silico modelling using the MD simulation method with all atom re-
solution, can play a role in the development of novel anti-bacterial
agents. Previously, a number of antimicrobial peptides have been si-
mulated with lipid bilayers, indicating that most of the antimicrobial
peptides bind to the lipid-water interface with the help of electrostatic
and hydrophobic interactions; the cationic residues interact with ne-
gatively charged phosphate groups of phospholipids, whereas hydro-
phobic residues become buried within the lipid core of the membrane
[12,13,14,15]. In addition, the importance of hydrogen bonding be-
tween cationic residues of the antimicrobial peptides and the phosphate
oxygens of lipids, has been shown for the case of magain2 and MSI-
78 [38]. Furthermore, the formation of Lys-phosphate salt bridges was
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reported when transportan10 localized to the lipid-water interface[15].
In general, our results here agree with the previously performed studies.
In this study, however, we report a novel behavior for a set of short β2,2-
amino acid derivatives at the lipid-water interface that contradicts the
general amphiphilic view of antimicrobial peptides. Namely, the com-
plete burial of all hydrophobic tails is not necessary for eﬃcient anti-
microbial activity. As mentioned above, the hydrophobic residues that
protrude from the membrane could even play an important role in the
yet unknown mode of action of β2,2-amino acid derivatives. This novel
feature might prove to be useful for designing more eﬃcient anti-
microbials in the future.
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